Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials

A. Belkouz; J. W. Wilmink; N. Haj Mohammad; J. Hagendoorn; J. de Vos-Geelen; C. H. C. Dejong; M. Y. V. Homs; B. Groot Koerkamp; T. M. van Gulik; M. G. H. van Oijen; C. J. A. Punt; H. Klumpen

doi:10.1016/j.critrevonc.2020.102975

Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials

A. Belkouz, J. W. Wilmink, N. Haj Mohammad, J. Hagendoorn, J. de Vos-Geelen, C. H. C. Dejong, M. Y. V. Homs, B. Groot Koerkamp, T. M. van Gulik, M. G. H. van Oijen, C. J. A. Punt, H. Klumpen^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Article number	102975
Number of pages	9
Journal	Critical Reviews in Oncology/Hematology
Volume	151
DOIs	https://doi.org/10.1016/j.critrevonc.2020.102975
Publication status	Published - Jul 2020

Keywords

Cholangiocarcinoma
Biliary tract cancer
Adjuvant therapy
Neoadjuvant therapy
Chemotherapy
Chemoradiotherapy
PERIHILAR CHOLANGIOCARCINOMA
GEMCITABINE CHEMOTHERAPY
GALLBLADDER CARCINOMA
PROGNOSTIC-FACTORS
PLUS GEMCITABINE
RESECTION
CISPLATIN
SURVIVAL
S-1
OXALIPLATIN

Access to Document

10.1016/j.critrevonc.2020.102975

Cite this

Belkouz, A., Wilmink, J. W., Mohammad, N. H., Hagendoorn, J., de Vos-Geelen, J., Dejong, C. H. C., Homs, M. Y. V., Koerkamp, B. G., van Gulik, T. M., van Oijen, M. G. H., Punt, C. J. A., & Klumpen, H. (2020). Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. Critical Reviews in Oncology/Hematology, 151, [102975]. https://doi.org/10.1016/j.critrevonc.2020.102975

Belkouz, A. ; Wilmink, J. W. ; Mohammad, N. Haj ; Hagendoorn, J. ; de Vos-Geelen, J. ; Dejong, C. H. C. ; Homs, M. Y. V. ; Koerkamp, B. Groot ; van Gulik, T. M. ; van Oijen, M. G. H. ; Punt, C. J. A. ; Klumpen, H. / Advances in adjuvant therapy of biliary tract cancer : an overview of current clinical evidence based on phase II and III trials. In: Critical Reviews in Oncology/Hematology. 2020 ; Vol. 151.

@article{43fdf78c6018442abe2767272f63fbb4,

title = "Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials",

keywords = "Cholangiocarcinoma, Biliary tract cancer, Adjuvant therapy, Neoadjuvant therapy, Chemotherapy, Chemoradiotherapy, PERIHILAR CHOLANGIOCARCINOMA, GEMCITABINE CHEMOTHERAPY, GALLBLADDER CARCINOMA, PROGNOSTIC-FACTORS, PLUS GEMCITABINE, RESECTION, CISPLATIN, SURVIVAL, S-1, OXALIPLATIN",

author = "A. Belkouz and Wilmink, {J. W.} and Mohammad, {N. Haj} and J. Hagendoorn and {de Vos-Geelen}, J. and Dejong, {C. H. C.} and Homs, {M. Y. V.} and Koerkamp, {B. Groot} and {van Gulik}, {T. M.} and {van Oijen}, {M. G. H.} and Punt, {C. J. A.} and H. Klumpen",

year = "2020",

month = jul,

doi = "10.1016/j.critrevonc.2020.102975",

language = "English",

volume = "151",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Science",

}

Belkouz, A, Wilmink, JW, Mohammad, NH, Hagendoorn, J, de Vos-Geelen, J , Dejong, CHC, Homs, MYV, Koerkamp, BG, van Gulik, TM, van Oijen, MGH, Punt, CJA & Klumpen, H 2020, 'Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials', Critical Reviews in Oncology/Hematology, vol. 151, 102975. https://doi.org/10.1016/j.critrevonc.2020.102975

Advances in adjuvant therapy of biliary tract cancer : an overview of current clinical evidence based on phase II and III trials. / Belkouz, A.; Wilmink, J. W.; Mohammad, N. Haj; Hagendoorn, J.; de Vos-Geelen, J.; Dejong, C. H. C.; Homs, M. Y. V.; Koerkamp, B. Groot; van Gulik, T. M.; van Oijen, M. G. H.; Punt, C. J. A.; Klumpen, H.

In: Critical Reviews in Oncology/Hematology, Vol. 151, 102975, 07.2020.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Advances in adjuvant therapy of biliary tract cancer

T2 - an overview of current clinical evidence based on phase II and III trials

AU - Belkouz, A.

AU - Wilmink, J. W.

AU - Mohammad, N. Haj

AU - Hagendoorn, J.

AU - de Vos-Geelen, J.

AU - Dejong, C. H. C.

AU - Homs, M. Y. V.

AU - Koerkamp, B. Groot

AU - van Gulik, T. M.

AU - van Oijen, M. G. H.

AU - Punt, C. J. A.

AU - Klumpen, H.

PY - 2020/7

Y1 - 2020/7

KW - Cholangiocarcinoma

KW - Biliary tract cancer

KW - Adjuvant therapy

KW - Neoadjuvant therapy

KW - Chemotherapy

KW - Chemoradiotherapy

KW - PERIHILAR CHOLANGIOCARCINOMA

KW - GEMCITABINE CHEMOTHERAPY

KW - GALLBLADDER CARCINOMA

KW - PROGNOSTIC-FACTORS

KW - PLUS GEMCITABINE

KW - RESECTION

KW - CISPLATIN

KW - SURVIVAL

KW - S-1

KW - OXALIPLATIN

U2 - 10.1016/j.critrevonc.2020.102975

DO - 10.1016/j.critrevonc.2020.102975

M3 - Review article

C2 - 32464483

VL - 151

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

M1 - 102975

ER -